Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WORK
651
DELISTED
Slack Technologies, Inc.
WORK
| $60M | 0.02% |
1,930,080
+1,871,056
| +3,170% | +$56.2M |
|
652
PUT
Expedia Group
EXPE
$39.4B
| $59.9M | 0.02% |
728,900
+99,000
| +16% | +$7.2M |
|
653
CALL
Crown Castle
CCI
$32.2B
| $59.7M | 0.02% |
356,900
+172,200
| +93% | +$27.7M |
|
654
PUT
Teladoc Health
TDOC
$1.26B
| $59.7M | 0.02% |
312,600
+30,300
| +11% | +$5.31M |
|
655
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $59.4M | 0.02% |
1,044,500
+339,500
| +48% | +$17M |
|
656
TechnipFMC
FTI
$30.1B
| $59.3M | 0.02% |
11,654,735
+9,935,846
| +578% | +$57.9M |
|
657
CALL
Bristol-Myers Squibb
BMY
$132B
| $59M | 0.02% |
1,003,100
-1,300,900
| -56% | -$77.8M |
|
658
XPO
XPO
$24.7B
| $59M | 0.02% |
2,207,068
-438,494
| -17% | -$10.5M |
|
659
CALL
Las Vegas Sands
LVS
$29.6B
| $58.9M | 0.02% |
1,293,600
-67,400
| -5% | -$3.17M |
|
660
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| $58.9M | 0.02% |
437,600
+171,800
| +65% | +$22.3M |
|
661
CALL
RTX Corp
RTX
$297B
| $58.7M | 0.02% |
953,400
-242,323
| -20% | -$15.1M |
|
662
PUT
General Mills
GIS
$20.8B
| $58.7M | 0.02% |
952,600
+297,400
| +45% | +$17.9M |
|
|
MNTA
663
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $58.7M | 0.02% |
1,763,985
+636,305
| +56% | +$20.3M |
|
664
CALL
Marriott International
MAR
$91.9B
| $58.7M | 0.02% |
684,500
+260,800
| +62% | +$22.7M |
|
665
PUT
BP
BP
$110B
| $58.6M | 0.02% |
2,513,300
+1,034,100
| +70% | +$24.8M |
|
666
Alliant Energy
LNT
$18.2B
| $58.4M | 0.02% |
1,221,113
-3,403,871
| -74% | -$166M |
|
667
Knight Transportation
KNX
$11.9B
| $58.4M | 0.02% |
1,399,011
-2,278,857
| -62% | -$86.9M |
|
668
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $58.1M | 0.02% |
200,200
-8,600
| -4% | -$2.33M |
|
669
CALL
Moderna
MRNA
$25.4B
| $58M | 0.02% |
903,100
+363,200
| +67% | +$19.9M |
|
670
PACCAR
PCAR
$68.8B
| $57.9M | 0.02% |
1,161,194
-2,253,381
| -66% | -$105M |
|
|
SYNH
671
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $57.9M | 0.02% |
994,645
+117,932
| +13% | +$6.34M |
|
672
Lincoln National
LNC
$8.67B
| $57.9M | 0.02% |
1,574,595
+669,580
| +74% | +$23.6M |
|
673
CALL
Colgate-Palmolive
CL
$74.1B
| $57.9M | 0.02% |
790,200
+217,000
| +38% | +$15.4M |
|
674
PUT
General Motors
GM
$75.8B
| $57.7M | 0.02% |
2,279,700
-430,900
| -16% | -$10.5M |
|
|
SCHW
675
PUT
Charles Schwab
SCHW
$190B
| $57.6M | 0.02% |
1,706,600
+1,055,100
| +162% | +$37.8M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.